GAMMA Investing LLC Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GAMMA Investing LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.3% during the first quarter, HoldingsChannel.com reports. The fund owned 6,115 shares of the medical equipment provider’s stock after acquiring an additional 518 shares during the quarter. GAMMA Investing LLC’s holdings in Intuitive Surgical were worth $3,029,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Castleark Management LLC grew its position in Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock worth $47,221,000 after acquiring an additional 2,990 shares in the last quarter. Ewing Morris & Co. Investment Partners Ltd. bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $454,000. Whalerock Point Partners LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $209,000. Tounjian Advisory Partners LLC bought a new position in shares of Intuitive Surgical during the 1st quarter valued at approximately $5,152,000. Finally, Brighton Jones LLC raised its holdings in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after buying an additional 731 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Gary Loeb sold 1,700 shares of the business’s stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the transaction, the executive vice president now owns 2,245 shares of the company’s stock, valued at $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 4,998 shares of company stock valued at $2,611,577. Company insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a “hold” rating to a “sell” rating and dropped their price objective for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. Evercore ISI dropped their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a “buy” rating in a research report on Monday, April 14th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Thursday, June 5th. Finally, Piper Sandler cut their target price on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $588.95.

Intuitive Surgical Trading Down 0.1%

Shares of ISRG stock opened at $533.71 on Friday. Intuitive Surgical, Inc. has a twelve month low of $413.82 and a twelve month high of $616.00. The stock has a fifty day simple moving average of $532.08 and a two-hundred day simple moving average of $536.80. The stock has a market capitalization of $191.29 billion, a price-to-earnings ratio of 78.26, a P/E/G ratio of 5.67 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the previous year, the company posted $1.50 earnings per share. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.